Ex Parte Edwards et al - Page 3




              Appeal No. 2005-0224                                                                                          
              Application No. 08/878,146                                                                                    
              evidence, as shown by some objective teaching in the prior art or by knowledge                                
              generally available to one of ordinary skill in the art that would have led that individual to                
              combine the relevant teachings of the references to arrive at the claimed invention.  See                     
              In re Fine, 837 F.2d 1071, 1074, 5 USPQ2d 1596, 1598 (Fed. Cir. 1988).                                        
                     It is the examiner’s position that (Final Rejection, page 2):                                          
                             Maa teaches methods of preparing a dry powder composition                                      
                     comprising spray freeze-drying an aqueous mixture of a protein under                                   
                     conditions to provide a respirable dry powder. Maa also teaches methods                                
                     of administering a therapeutically effective dose of a therapeutic protein to                          
                     a patient comprising administering to the alveolar regions of the lungs of                             
                     the patient a spray freeze dried therapeutic protein dry powder                                        
                     composition (col. 2, lines 28-55).                                                                     
                             The term “powder” is described as a composition that consists of                               
                     finely dispersed solid particles that are relatively free flowing and capable                          
                     of being readily dispersed in an inhalation device and subsequently                                    
                     inhaled by a patient so that the particles can reach the alveoli of the lung.                          
                     Thus, the powder is respirable and suitable for pulmonary delivery.  The                               
                     average particle size ranges from about 5 µm to about 30 µm. [T]he                                     
                     preferred average particle size is 6-8 µm.  The FPF, fine powder fraction,                             
                     is preferably at least 10%, and especially preferred at 40-50%.  The                                   
                     particles have a tap density of less than about 0.8 g/cm3, with tap                                    
                     densities of less than about 0.4 g/cm3 being preferred and less than about                             
                     0.1 g/cm3 being especially preferred (see col. 5, line 30 to col. 6, line 33).                         
                     The examiner acknowledges that, “Maa does not specifically disclose the mass                           
              of the particles delivered,” however, argues that “it clearly teaches powders dispersed                       
              from the dose chamber of the inhalation device.”  Final Rejection, page 3.                                    
                     The examiner concludes (Final Rejection, pages 3-4) that:                                              
                     It would have been obvious to one of ordinary skill in the art at the time the                         
                     invention was made to have modified the teachings of Maa et al by                                      
                     concentrating on more specific volume of receptacle and mass of particles                              
                     delivered because knowing the specific values regarding dosages in                                     
                     treating certain disorders is very important and helpful to health care                                
                                                             3                                                              





Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007